Modular Medical, Inc.: Form 10-Q for the period ended Sep 30, 2018
Filed with the SEC on Nov 19, 2018 and accepted by EDGAR at Nov 19, 2018, 16:42 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2018-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2018-07-01 to 2018-09-30 | $0 | us-gaap:Revenues |
| Revenue | 6 months2018-04-01 to 2018-09-30 | $0 | us-gaap:Revenues |
| Research and development | 3 months2018-07-01 to 2018-09-30 | $367.6k | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2018-04-01 to 2018-09-30 | $503.3k | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2018-07-01 to 2018-09-30 | −$549.0k | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2018-04-01 to 2018-09-30 | −$804.2k | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2018-07-01 to 2018-09-30 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2018-04-01 to 2018-09-30 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2018-07-01 to 2018-09-30 | −$543.8k | us-gaap:NetIncomeLoss |
| Net income | 6 months2018-04-01 to 2018-09-30 | −$793.3k | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2018-07-01 to 2018-09-30 | −$0.03 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 6 months2018-04-01 to 2018-09-30 | −$0.05 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted shares (weighted) | 3 months2018-07-01 to 2018-09-30 | 15,983,273 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2018-04-01 to 2018-09-30 | 15,983,273 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2018-04-01 to 2018-09-30 | −$576.1k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2018-04-01 to 2018-09-30 | $32.8k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2018-09-30 | $3.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2018-09-30 | $3.7m | us-gaap:AssetsCurrent |
| Total assets | At period end2018-09-30 | $3.7m | us-gaap:Assets |
| Total liabilities | At period end2018-09-30 | $46.8k | us-gaap:Liabilities |
| Shareholders' equity | At period end2018-09-30 | $3.7m | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2018-09-30 | 15,983,273 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001019056-18-001081. Last ingested by Listed: Nov 10, 2026, 07:32 ET. Listed shows no prices and gives no investment advice.